The company has strong fundamentals. More than 70% of listed companies have a lower mix of growth, profitability, debt and visibility criteria.
The company has solid fundamentals for a short-term investment strategy.
UnitedHealth Group accounts for 5.08 % of our USA Portfolio. A trade is currently open since 11/02/2015 with a purchase price of $ 119.36. Discover the other 19 stocks of the USA portfolio managed by the 4-traders portfolio management team.
Historically, the company has been releasing figures that are above expectations.
The company has attractive valuation levels with a low EV/sales ratio compared with its peers.
Over the last twelve months, the sales forecast has been frequently revised upwards.
For the past twelve months, EPS forecast has been revised upwards.
For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
Analysts covering this company mostly recommend stock overweighting or purchase.
The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
The tendency within the weekly time frame is positive above the technical support level at 209.9 USD